GenScript's Presence in Japan Relocated from Osaka to Tokyo
Jan 19, 2010
PISCATAWAY, N.J., Jan 19, 2009 -Internationally recognized biology contract research organization GenScript USA Inc. announced today that it has relocated its Japanese office from Osaka to Tokyo.
The new address and contact of GenScript's Japanese presence in Tokyo is:
7F, Kanda-Central Building B,
1-7, Suda-cho, Kanda, Chiyoda-ku,
Tokyo 101-0041, Japan
The relocation will bring more efficient coordination between GenScript’s staff in Japan as well better services for its Japanese customers. “The relocation of our presence to Tokyo has profound meanings for GenScript. This way, we can expand our Japanese market right from the center of the country. This bodes a brand new beginning for GenScript’s business in Japan.” says Dr. Frank Zhang, GenScript’s CEO.
GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
# # # #
For further information, please contact:
Executive Vice President
GENSCRIPT USA INC.
Your Innovation Partner in Drug Discovery!